PKC alpha Antikörper (AA 305-325)
Kurzübersicht für PKC alpha Antikörper (AA 305-325) (ABIN2342863)
Target
Alle PKC alpha (PKCa) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 305-325
-
Sequenz
- FEKAKLGPAG NKVISPEDRK Q
-
Kreuzreaktivität
- Human, Säugetier
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Ma
-
Produktmerkmale
- Protein Kinase C, alpha (AAG6, MGC129900, MGC129901, PKCA, PKC-A, PKC-alpha, PRKACA, Protein kinase C alpha type)
-
Immunogen
- Synthetic peptide corresponding to a distinct C-terminal region, (FEKAKLGPAGNKVISPEDRKQ residues 305-325) from human protein kinase C alpha.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as antiserum containing 0.05 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- PKC alpha (PKCa) (Protein Kinase C, alpha (PKCa))
-
Andere Bezeichnung
- Protein Kinase C, alpha
-
UniProt
- P17252
-
Pathways
- WNT Signalweg, T-Zell Rezeptor Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, Cell-Cell Junction Organization, Regulation of G-Protein Coupled Receptor Protein Signaling, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Target
-